Tourmaline Oil Corp. closed 16.0% short of its 52-week high of C$70.83, which the company achieved on February 21st.

Tourmaline Oil Corp. closed 19.5% below its 52-week high of C$70.83, which the company reached on February 21st.

CIBC analyst Jamie Kubik lowered the firm’s price target on Tourmaline Oil (TRMLF) to C$72.50 from C$80 and keeps an Outperformer rating on the ...

Tourmaline welcomes back Jeff Zuckerman as Managing Director, who rejoins the firm after four years bringing his expertise ...

Truist lowered the firm’s price target on Tourmaline Bio (TRML) to $63 from $74 but keeps a Buy rating on the shares. The firm is also raising ...

The Kat Florence Lumina, a flawless 181.61-carat Paraiba tourmaline, is completing its global debut tour with final ...

Tourmaline Bio's Pacibekitug shows promise in IL-6 targeting for autoimmune diseases. Learn about its potential and ongoing trials. Read why TRML is a hold.

The French winemaker is celebrating its milestone year with the launch of Côtes de Provence Rosé Tourmaline 2024 and a new label for Côtes du Rhône Les Galets.

This summary is reviewed by TRD Staff. Tourmaline Capital Partners paid $76 million for the Columbus Center office complex in Coral Gables, which was facing foreclosure due to debt issues of the ...

Jeff Zuckerman has returned to Tourmaline as a Managing Director where he will oversee senior trading responsibilities. He is ...

Tourmaline Oil had a return on equity of 11.06% and a net margin of 27.12%. The business had revenue of $1.16 billion for the quarter, compared to analysts’ expectations of $1.59 billion.